News Headlines Article

Insurers May Cover Costly Hepatitis C Drugs Only For The Very Ill
National Public Radio

In the past year, hepatitis C drugs that promise higher cure rates and fewer side effects have given fresh hope to millions who are living with the chronic liver disease. But many patients whose livers haven’t been significantly scarred by the virus face a vexing reality: They’re not sick enough to qualify for the drugs that could prevent them from getting sicker.

An estimated 3.2 million people are infected with hepatitis C virus. Many public and private insurers are restricting access to treatment to those who already have serious liver damage. The treatment cost per patient is roughly $95,000 or more for a 12-week course of treatment.

Commands